systemic embolism Tagged Articles
Kidney disease increases risk of stroke in atrial fibrillation patients
Kidney disease further increases the risk of stroke in patients with atrial fibrillation, according to a new study published in the New England Journal of Medicine.
Drug company lowers price of controversial blood thinner Pradaxa
Boehringer Ingelheim has announced it is reducing the cost of its oral blood thinner, Pradaxa (dabigatran etexilate), in the UK by 13 percent, a move that the company hopes will encourage the National Health Service (NHS) to make sure the
UK advisory panel recommends approval of controversial Pradaxa
Boehringer Ingelheim GmbH’s blood thinner Pradaxa has won the recommendation from the United Kingdom’s medical-cost regulator as a treatment to prevent strokes in patients with a life threatening type of irregular heartbeat. The recommendation was made in spite of concerns
FDA undertaking priority review of new anti-clotting drug
The Food and Drug Administration (FDA) is undertaking a priority review for an experimental anti-clotting drug for the prevention of strokes and systemic embolism in patients with atrial fibrillation, an irregular heartbeat that raises the risk for serious blood clots.